Intradermal delivery: a promising method for breast cancer immunotherapy
Female breast cancer was the second leading cause of global cancer in 2022. (2.3 million new cases) Fortunately, early detection and innovative approaches save lives, and understanding the latest advancements is key.
This white paper explores the intradermal delivery route as a promising method for breast cancer disease staging and breast cancer immunotherapy strategies.
What’s inside?
✔️ Novel treatment strategies: cancer vaccines & immunotherapy
✔️ Different types of breast cancer vaccines
✔️ The role of intradermal delivery in treatment strategies
✔️ How VAX-ID can support breast cancer immunotherapy